Stents Market Size By Product (Vascular Stents [Coronary Stents {Bare Metal Stents, Drug Eluting Stents, Bioresorbable Stents}, Peripheral Stents {Iliac Stents, Femoral-Popliteal Stents, Renal Stents, Carotid Stents}, Neurovascular Stents], Non-vascular Stents), By Material (Metal, Polymer), By Type, (Self-expandable Stents, Balloon-expandable Stents), By End-use (Hospitals, Ambulatory Surgical Centers), Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Italy, Spain, Japan, China, India, Australia, Singapore, Brazil, Mexico, South Africa, Saudi Arabia), Application Potential, Price Trends, Competitive Market Share & Forecast, 2020 - 2026

Published Date: Jan 2021  |  Report ID: GMI3372  |  Authors: Sumant Ugalmugle, Rupali Swain

Report Format: PDF   |   Pages: 300   |   Base Year: 2019

Summary Table of Contents Industry Coverage Methodology

Industry trends

Stents Market size exceeded USD 11.2 billion in 2019 and is poised to grow at over 3.9% CAGR between 2020 and 2026. 

Stents Market
Get more details on this report - Request Free Sample PDF

Rapid technological advancements leading to high accuracy level and more reliability in stents are major factors driving the industry growth. Frequent upgradation of technology allows introduction of minimally invasive stents. Also, significant increase in number of people suffering from coronary heart diseases will lead to high demand for percutaneous coronary intervention procedure.

Increasing number of coronary artery disease and peripheral vascular disorders globally will positively impact the stents market revenue. Growing number of patient pool with chronic disease will drive the demand for percutaneous coronary intervention and peripheral vascular procedures. According to report published by the American Heart Association (AHA) on heart disease and stroke statistics in 2017, about 90 million people suffered from coronary heart disease annually in U.S. As number of people suffering from coronary artery and peripheral vascular diseases is rising steadily, the demand for percutaneous coronary intervention and peripheral vascular procedures will increase. Thus, this will lead to increase in adoption rate of stents.

Stents are essential medical devices, used in critical life-saving procedures. Thus, it can be expected that the COVID-19 crisis will not directly impact the manufacturing of such devices. However, logistical disruptions can be expected especially due to the reliance on Chinese manufacturing. This could disrupt the supply of stents and cause temporary shortages, potentially increasing the prices of stents.

Stringent regulation approvals may slow down the market expansion

Strict regulatory landscape may act as a barrier in growth of the stents market. Various governments and organizations dictate guidelines and rules for safer and effective employment of stents. For instance, the European Association of Percutaneous Cardiovascular Interventions (EAPCI) provides clinical and non-clinical guidelines for stents. Also, the U.S. FDA performs extensive systemic review of literature and pre-clinical trials in animals before granting approval for stents. Moreover, Office of Combination Products (OCP) have also published regulations for the use of drug eluting stents by surgeons and physicians. These stringent rules for employment of stents will significantly hinder the industry growth.

Efforts by various manufacturers to develop technologically advanced coronary vascular stents

Stents Market

Get more details on this report - Request Free Sample PDF

The vascular stents market accounted for revenue share of over 91% in 2019 owing to growing burden of cardiovascular disease (CVD). For instance, according to the American Heart Association (AHA) report, the CVD prevalence was high in the U.S., Central Europe, North Africa and in Middle East in 2018. The report also stated that, nearly 30.3 million U.S. adults were diagnosed with cardiovascular disease in 2018. Thus, rising prevalence of disease burden in various regions coupled with increasing usage of vascular stents in such disease treatment solution and procedures will upsurge the segment growth. Furthermore, vascular stents are used in opening narrowed blood vessels and clearing blockages.

Various advantages associated with metal stents will escalate the segment growth

The metal stents segment value was around USD 9.1 billion in 2019. Metal is the material of choice for stents due to advantages such as lower rates of stent fracture, flexibility, and biocompatibility. Integration of metallic stents with biodegradable polymers to overcome the limitations of conventional will be another factor propelling the segment growth. Furthermore, metal stents reduce the incidence of abrupt vessel closure and restenosis compared with balloon angioplasty, thereby decreasing the rate of target lesion revascularization (TLR).

Increasing adoption of stents in hospital settings will drive the market demand

Hospital segment dominated a stent market share of 74.5% in 2019. Hospitals are well equipped with medical devices including stents, as they are essential devices and widely used in various minimally and surgical procedures. Changing lifestyle, adoption of unhealthy habits such as alcohol and smoking along with environmental factors including pollution adds in disease populations. Therefore, significant increase in hospital admissions will stimulate the demand for advanced treatment solutions offering immense growth opportunities for the market. Furthermore, availability of skilled healthcare professionals and the quality of post-operative care will supplement the segment growth.

Balloon-expandable stents support high radial outward force due to their rigidity

The balloon-expandable stents segment size was USD 7.2 billion in 2019. Balloon expandable stents support high radial outward force due to their rigidity. Furthermore, they offer long-term integrity and higher elasticity. These advantages of balloon-expandable will positively impact the market expansion. Furthermore, focus of various market players to develop innovative product will further boost the market size.

Growing incidence rate of cardiovascular disease along with rising geriatric population in North America

Get more details on this report - Request Free Sample PDF

North America stents market held more than 26% revenue share in 2019 attributed to increasing incidence of cardiovascular disease coupled with rising geriatric population in the region. For instance, according to the Center for American Heart Association, cardiovascular disease (CVD) is listed as one of the leading causes of death, accounted for more than 800,000 deaths in the U.S. in 2018, that represents approximately 1 of every 3 deaths. Similarly, according to the U.S. Census Bureau, there were more than 54 million U.S. residents aged 65 years and older in 2019. This number involves various disease conditions and disorder such as coronary heart disease and angioplasty, among others. Thus, usage of stents in such disease condition or procedures will impel the North American market expansion.

Adoption of business strategies will pave growth opportunities for companies operating in the market

Prominent players operating in the stents industry include Abbott, B Braun, Biosensors, Biotronik, Boston Scientific, Medtronic, Stryker Corporation and Terumo Corporation among few other players. New product launch & approval, acquisition and collaboration are the most adopted business strategies to sustain market position.

Some of the recent industry developments:

  • In September 2019, Terumo announced the introduction of a new radial to periphery self-expanding stent. The device is specially designed for above-the-knee PAD interventions via radial access, incorporating Rapid Exchange (RX) technology and innovative bare metal stent design. This new product launch helped company to strengthen their product portfolio and increase revenue generation
  • In February 2019, Biotronik received approval from U.S. FDA for its Orsiro drug eluting stent that is an ultrathin bioresorbable stent. The product is intended for percutaneous coronary intervention (PCI) procedures. This new product launch strategy enabled company to strengthen its product portfolio and expand the existing customer base.

The stents market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2015 to 2026, for the following segments:

Market, By Product

  • Vascular stents
    • Coronary stents
      • Bare metal stents
      • Drug eluting stents
      • Bioresorbable stents
    • Peripheral stents
      • Iliac stents
      • Femoral-popliteal stents
      • Renal stents
      • Carotid stents
    • Neurovascular stents
  • Non-vascular stents

Market, By Material

  • Metal
  • Polymer

Market, By Type

  • Self-expandable stents
  • Balloon-expandable stents

Market, By End-use

  • Hospitals
  • Ambulatory surgical centers
  • Others

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • Singapore
  • Latin America
    • Brazil
    • Mexico
  • Middle East & Africa
    • South Africa
    • Saudi Arabia


Frequently Asked Questions (FAQ) :

The market size for stents was more than USD 11.2 billion in 2019 and will expand at over 3.9% CAGR through 2026 owing to high reliability and accuracy level in the products available today.
The vascular stents held more than 91% of the overall market in terms of revenue during 2019 due to the rising prevalence of cardiovascular diseases (CVD) across the U.S., Europe and MEA regions.
The market share of metal stents had reached USD 9.1 billion in 2019 and will grow owing to advantages like flexibility, low stent fracture rates and integration with biocompatible polymers.
The balloon-expandable stents segment share was pegged at USD 7.2 billion in 2019 and will rise due to benefits like improved elasticity and long-term integrity.
North America industry accounted for over 26% of the global revenue share in 2019 with the growing prevalence of cardiovascular disease (CVD) and surging geriatric population.

Premium Report Details

  • Published Date: Jan 2021
  • Pages: 300
  • Tables: 708
  • Charts / Figures: 20
  • Companies covered: 14
  • Countries covered: 16

Get a report that explains COVID-19 impact on this market

Buy Now

Need a Discount? Get in touch with us for special pricing

Request Discount

 Connect with our sales team

Chat with us
We use cookies to enhance user experience. (Privacy Policy) X